|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 03-30 | BioVentix confident on future despite profit decline in first half | AN |
| 03-30 | WINNERS & LOSERS: boohoo to beat view; Abingdon Health wins deals | AN |
Company Valuation: Bioventix PLC
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 206.8 | 179.7 | 201 | 229.7 | 143.7 | 90.39 |
| Change | - | -13.1% | 11.82% | 14.29% | -37.44% | -37.09% |
| Enterprise Value (EV) 1 | 206.8 | 173.6 | 201 | 223.7 | 138.6 | 85.5 |
| Change | - | -16.06% | 15.76% | 11.3% | -38.03% | -38.32% |
| P/E | 31x | 23.6x | 24.3x | 28.8x | 19.2x | 12.9x |
| PBR | - | 15.2x | - | 19.1x | 12.4x | 8.27x |
| PEG | - | 1.7x | 2.86x | -8.41x | -3.07x | -1.99x |
| Capitalization / Revenue | 18.9x | 15.3x | - | 16.9x | 11x | 7.23x |
| EV / Revenue | 18.9x | 14.8x | - | 16.4x | 10.6x | 6.84x |
| EV / EBITDA | - | 18x | - | 20.7x | 13.7x | 8.98x |
| EV / EBIT | - | 18.7x | - | 20.8x | 14x | 9.18x |
| EV / FCF | - | 23x | - | 26.9x | 19.8x | 11.4x |
| FCF Yield | - | 4.35% | - | 3.72% | 5.06% | 8.75% |
| Dividend per Share 2 | - | 1.26 | - | 1.55 | 1.5 | 1.5 |
| Rate of return | - | 3.65% | - | 3.52% | 5.45% | 8.67% |
| EPS 2 | 1.279 | 1.459 | 1.583 | 1.529 | 1.433 | 1.34 |
| Distribution rate | - | 86.4% | - | 101% | 105% | 112% |
| Net sales 1 | 10.93 | 11.72 | - | 13.61 | 13.12 | 12.5 |
| EBITDA 1 | - | 9.662 | - | 10.79 | 10.09 | 9.518 |
| EBIT 1 | - | 9.274 | - | 10.77 | 9.904 | 9.318 |
| Net income 1 | 6.731 | 7.674 | 8.372 | 8.097 | 7.584 | 7.112 |
| Net Debt 1 | - | -6.127 | - | -5.999 | -5.079 | -4.894 |
| Reference price 2 | 39.70 | 34.50 | 38.50 | 44.00 | 27.50 | 17.30 |
| Nbr of stocks (in thousands) | 5,209 | 5,209 | 5,220 | 5,220 | 5,225 | 5,225 |
| Announcement Date | 10/18/21 | 10/24/22 | 10/30/23 | 10/28/24 | 10/27/25 | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.07x | 6.11x | 18.29x | 0.94% | 50.14B | |
| -21.38x | 253.2x | -23.09x | -.--% | 44.85B | |
| 33.98x | 3.29x | 14.19x | -.--% | 43.43B | |
| 47.39x | 5.49x | 30x | -.--% | 41.14B | |
| 28.29x | 8.56x | 21.63x | 0.41% | 32.92B | |
| 33.72x | 5.52x | 25.09x | -.--% | 16.55B | |
| 24.26x | 2.11x | 9.12x | 1.11% | 14.65B | |
| 78.05x | 4.1x | 15.91x | -.--% | 13.93B | |
| Average | 32.30x | 36.05x | 13.89x | 0.31% | 32.2B | |
| Weighted average by Cap. | 27.59x | 48.49x | 12.48x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BVXP Stock
- BVNXF Stock
- Valuation Bioventix PLC
Select your edition
All financial news and data tailored to specific country editions
